This inventor holds 1 USPTO granted patent. Top assignee: Kangstem Biotech Co., Ltd.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Jong Chan Ahn: Innovator in Stem Cell Technology
Introduction: Jong Chan Ahn is a prominent inventor based in Gyeonggi-do, South Korea. He has made significant contributions to the field of stem cell research, particularly in the production of umbilical cord blood-derived stem cells. His innovative approach has the potential to enhance the efficacy of stem cell therapies.
Latest Patents: Jong Chan Ahn holds a patent titled "Method for Producing Umbilical Cord Blood-Derived Stem Cell with Enhanced Efficacy." This patent reflects his commitment to advancing medical science and improving treatment options for patients.
Career Highlights: Ahn is currently associated with Kangstem Biotech Co., Ltd., a company dedicated to developing cutting-edge biotechnological solutions. His work at Kangstem Biotech has positioned him as a key player in the stem cell research community.
Collaborations: Ahn collaborates with talented professionals in his field, including Mijin Kim and Seunghee Lee. These partnerships foster innovation and contribute to the success of their projects.
Conclusion: Jong Chan Ahn's contributions to stem cell technology exemplify the impact of innovative thinking in medicine. His work continues to inspire advancements in the field and holds promise for future therapeutic applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile